Coronavirus Strategies to Boost Community Coronavirus Strategies to Boost Community

ADVERTISEMENT

Liars, Ghostwriters and Whistleblowers: How Bayer Made the Worst Deal in History

Analysis by Dr. Joseph Mercola Fact Checked

how bayer made the worst deal in history

Story at-a-glance -

  • Bayer acquired Monsanto in 2018 for $63 billion, as lawsuits mounted against the chemical giant over Roundup herbicide’s cancer link
  • At least 13,400 lawsuits have been filed from people who claim exposure to their glyphosate-containing Roundup caused them health problems, including cancer
  • The first three lawsuits have already ended in favor of the plaintiffs, leaving Bayer saddled with billions in damages — and that’s only the beginning
  • Some experts are calling Bayer’s acquisition of Monsanto “the worst deal ever,” and the company is scrambling to appeal and trying to convince courts to toss out the lawsuits because U.S. regulatory agencies continue to side with industry and assert glyphosate is safe

Bayer acquired Monsanto in 2018 for $63 billion, a purchase Bayer CEO Werner Baumann said would further their goal of creating a leading agriculture company. Bayer is now the largest seed and pesticide company in the world, but it might not stay that way for long, as lawsuits mount against the chemical giant over Roundup herbicide's cancer link.

At least 13,400 lawsuits have been filed from people who claim exposure to their glyphosate-containing Roundup caused them health problems, including cancer. The first three lawsuits have already ended in favor of the plaintiffs, leaving Bayer saddled with billions in damages — and that's only the beginning.


Read the Full Article for Free!
Subscribe to the #1 Natural Health Newsletter
  • Unlock censored health information that Google doesn't want you to read
  • Keep your privacy secure — We are no longer active on Facebook and are blocking our content from Google search to ensure your privacy stays protected
  • Get access to all of Dr. Mercola's health articles, E-books and special reports

Existing Subscribers: Enter your email address for instant access